Cardiovascular Disease Doctors in Camden, SC Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Dr. William L Schoolmeester, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1045 W Dekalb St, Camden, SC 29020 Phone: 803-432-8622    Fax: 803-432-8624

Dr. Robert G Kiger, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1300 Haile St, Camden, SC 29020 Phone: 803-254-3278    Fax: 803-255-2715

Paul A Zimmermann, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1330 Haile St, Camden, SC 29020 Phone: 803-432-6771    Fax: 803-424-1900

David P. Christenberry, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1102 Roberts St, Camden, SC 29020 Phone: 803-432-7682    Fax: 803-424-2423

Mitchell Todd Alderson, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1330 Haile St, Camden, SC 29020 Phone: 803-432-6771    Fax: 803-424-1900

News Archive

Study examines adherence of U.S. adults to physical activity guidelines

The proportion of U.S. adults adhering to the "Physical Activity Guidelines for Americans" from the U.S. Department of Health and Human Services didn't significantly improve between 2007 and 2016 but time spent sitting increased.

ASGE Endoscopy Unit Recognition Program identifies 10 endoscopy units to promote quality care

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 10 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States. The ASGE Endoscopy Unit Recognition Program honors endoscopy units that follow the ASGE guidelines on privileging, quality assurance, endoscopy reprocessing and CDC infection control guidelines. To date, 134 endoscopy units have been recognized by ASGE.

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.

Bochum's medics use autologous cord blood to treat infantile cerebral palsy

Bochum's medics have succeeded in treating cerebral palsy with autologous cord blood. Following a cardiac arrest with severe brain damage, a 2.5 year old boy had been in a persistent vegetative state - with minimal chances of survival. Just two months after treatment with the cord blood containing stem cells, the symptoms improved significantly; over the following months, the child learned to speak simple sentences and to move.

Scientists identify how cell architecture changes during formation of gametes

Scientists using high-powered microscopes have made a stunning observation of the architecture within a cell - and identified for the first time how the architecture changes during the formation of gametes, also known as sex cells, in order to successfully complete the process.

Read more Medical News

› Verified 5 days ago